<p>Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.</p><p>This episode covers ADHD in youth with Dr. Daniel Gorman, an Associate Professor in the Department of Psychiatry at the University of Toronto and a Staff Psychiatrist at The Hospital for Sick Children. Dr Gorman’s clinical and academic interests include ADHD, Tourette syndrome, obsessive-compulsive disorder, child psychopharmacology, psychiatric education, and narrative medicine. He is highly involved in resident teaching and clinical supervision, and from 2014 to 2022 he was the Program Director for the Child and Adolescent Psychiatry subspecialty program at the University of Toronto.</p><p>Dr. Gorman has given over 85 invited presentations and authored or co-authored over 35 peer-reviewed articles and book chapters, mainly related to childhood neuropsychiatric disorders and their pharmacological management. He also contributed to several Canadian guidelines, including guidelines on cardiac risk assessment before the use of stimulants, management of tic disorders, pharmacotherapy for childhood disruptive and aggressive behaviour, and pharmacogenetic testing for children treated with psychiatric medications.</p><p>The learning objectives for this episode are as follows:</p><p>By the end of this episode, the listener will be able to…</p><ol><li>Review diagnostic criteria for ADHD</li><li>Describe important considerations in making the diagnosis of ADHD</li><li>Describe psychosocial aspects of management of ADHD</li><li>Outline the pharmacological management of ADHD</li></ol><p><strong>Guest:</strong> Dr. Daniel Gorman</p><p><strong>Hosts:</strong> Dr. Kate Braithwaite, Dr. Shaoyuan Wang (PGY-4), Matthew Cho (MS-4)</p> <p><strong>Audio editing by:</strong> Dr. Angad Singh (PGY-1)</p><p><strong>Resources:</strong></p><ul><li>CADDRA - Canadian ADHD Resource Alliance: <a href="https://adhdlearn.caddra.ca/wp-content/uploads/2022/08/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf" rel="ugc noopener noreferrer" target="_blank"> Canadian ADHD Practice Guidelines, 4.1 Edition</a>, Toronto ON; CADDRA, 2020.</li></ul> <p><strong>References:</strong></p><ul><li>American Psychiatric Association. (2013). <em>Diagnostic and statistical manual of mental disorders</em> (5th ed.). <a href="https://doi.org/10.1176/appi.books.9780890425596" rel="ugc noopener noreferrer" target="_blank">https://doi.org/10.1176/appi.books.9780890425596</a></li><li>Biederman, J., DiSalvo, M., Fried, R., Woodworth, K. Y., Biederman, I., &amp; Faraone, S. V. (2019). Quantifying the protective effects of stimulants on functional outcomes in attention-deficit/hyperactivity disorder: A focus on number needed to treat statistic and sex effects. <em>Journal of Adolescent Health</em>, <em>65</em>(6), 784–789. <a href="https://doi.org/10.1016/j.jadohealth.2019.06.016" rel="ugc noopener noreferrer" target="_blank">https://doi.org/10.1016/j.jadohealth.2019.06.016</a></li><li>Peterson, B. S., Trampush, J., Brown, M., Maglione, M., Bolshakova, M., Rozelle, M., Miles, J., Pakdaman, S., Yagyu, S., Motala, A., &amp; Hempel, S. (2024). Tools for the diagnosis of ADHD in children and adolescents: A systematic review. <em>Pediatrics</em>, <em>153</em>(4), e2024065854. <a href="https://doi.org/10.1542/peds.2024-065854" rel="ugc noopener noreferrer" target="_blank">https://doi.org/10.1542/peds.2024-065854</a></li><li>Fedder, D., Patel, H., &amp; Saadabadi, A. (2018). Atomoxetine. <em>StatPearls</em>. Retrieved January 31, 2025, from <a href="https://www.ncbi.nlm.nih.gov/books/NBK493234/" rel="ugc noopener noreferrer" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK493234/</a></li><li>Canadian Pediatric Society. (2022). Mental health: Screening tools and rating scales. <em>Canadian Pediatric Society</em>. Retrieved January 31, 2025, from <a href="https://cps.ca/mental-health-screening-tools" rel="ugc noopener noreferrer" target="_blank">https://cps.ca/mental-health-screening-tools</a></li></ul><p>For more PsychEd, follow us on Instagram (<a href="https://www.instagram.com/psyched.podcast/" rel="ugc noopener noreferrer" target="_blank">@psyched.podcast</a>), X (<a href="https://twitter.com/psychedpodcast" rel="ugc noopener noreferrer" target="_blank">@psychedpodcast</a>), and Facebook (<a href="https://www.facebook.com/PsychEdPodcast" rel="ugc noopener noreferrer" target="_blank">PsychEd Podcast</a>). You can provide feedback by email at <a href="mailto:psychedpodcast@gmail.com" rel="ugc noopener noreferrer" target="_blank">psychedpodcast@gmail.com</a>. For more information, visit our website at <a href="http://psychedpodcast.org/" rel="ugc noopener noreferrer" target="_blank">psychedpodcast.org</a>.</p>

PsychEd: Educational Psychiatry Podcast

PsychEd

PsychEd Episode 66: ADHD in Youth with Dr. Daniel Gorman

JAN 31, 202572 MIN
PsychEd: Educational Psychiatry Podcast

PsychEd Episode 66: ADHD in Youth with Dr. Daniel Gorman

JAN 31, 202572 MIN

Description

<p>Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.</p><p>This episode covers ADHD in youth with Dr. Daniel Gorman, an Associate Professor in the Department of Psychiatry at the University of Toronto and a Staff Psychiatrist at The Hospital for Sick Children. Dr Gorman’s clinical and academic interests include ADHD, Tourette syndrome, obsessive-compulsive disorder, child psychopharmacology, psychiatric education, and narrative medicine. He is highly involved in resident teaching and clinical supervision, and from 2014 to 2022 he was the Program Director for the Child and Adolescent Psychiatry subspecialty program at the University of Toronto.</p><p>Dr. Gorman has given over 85 invited presentations and authored or co-authored over 35 peer-reviewed articles and book chapters, mainly related to childhood neuropsychiatric disorders and their pharmacological management. He also contributed to several Canadian guidelines, including guidelines on cardiac risk assessment before the use of stimulants, management of tic disorders, pharmacotherapy for childhood disruptive and aggressive behaviour, and pharmacogenetic testing for children treated with psychiatric medications.</p><p>The learning objectives for this episode are as follows:</p><p>By the end of this episode, the listener will be able to…</p><ol><li>Review diagnostic criteria for ADHD</li><li>Describe important considerations in making the diagnosis of ADHD</li><li>Describe psychosocial aspects of management of ADHD</li><li>Outline the pharmacological management of ADHD</li></ol><p><strong>Guest:</strong> Dr. Daniel Gorman</p><p><strong>Hosts:</strong> Dr. Kate Braithwaite, Dr. Shaoyuan Wang (PGY-4), Matthew Cho (MS-4)</p> <p><strong>Audio editing by:</strong> Dr. Angad Singh (PGY-1)</p><p><strong>Resources:</strong></p><ul><li>CADDRA - Canadian ADHD Resource Alliance: <a href="https://adhdlearn.caddra.ca/wp-content/uploads/2022/08/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf" rel="ugc noopener noreferrer" target="_blank"> Canadian ADHD Practice Guidelines, 4.1 Edition</a>, Toronto ON; CADDRA, 2020.</li></ul> <p><strong>References:</strong></p><ul><li>American Psychiatric Association. (2013). <em>Diagnostic and statistical manual of mental disorders</em> (5th ed.). <a href="https://doi.org/10.1176/appi.books.9780890425596" rel="ugc noopener noreferrer" target="_blank">https://doi.org/10.1176/appi.books.9780890425596</a></li><li>Biederman, J., DiSalvo, M., Fried, R., Woodworth, K. Y., Biederman, I., &amp; Faraone, S. V. (2019). Quantifying the protective effects of stimulants on functional outcomes in attention-deficit/hyperactivity disorder: A focus on number needed to treat statistic and sex effects. <em>Journal of Adolescent Health</em>, <em>65</em>(6), 784–789. <a href="https://doi.org/10.1016/j.jadohealth.2019.06.016" rel="ugc noopener noreferrer" target="_blank">https://doi.org/10.1016/j.jadohealth.2019.06.016</a></li><li>Peterson, B. S., Trampush, J., Brown, M., Maglione, M., Bolshakova, M., Rozelle, M., Miles, J., Pakdaman, S., Yagyu, S., Motala, A., &amp; Hempel, S. (2024). Tools for the diagnosis of ADHD in children and adolescents: A systematic review. <em>Pediatrics</em>, <em>153</em>(4), e2024065854. <a href="https://doi.org/10.1542/peds.2024-065854" rel="ugc noopener noreferrer" target="_blank">https://doi.org/10.1542/peds.2024-065854</a></li><li>Fedder, D., Patel, H., &amp; Saadabadi, A. (2018). Atomoxetine. <em>StatPearls</em>. Retrieved January 31, 2025, from <a href="https://www.ncbi.nlm.nih.gov/books/NBK493234/" rel="ugc noopener noreferrer" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK493234/</a></li><li>Canadian Pediatric Society. (2022). Mental health: Screening tools and rating scales. <em>Canadian Pediatric Society</em>. Retrieved January 31, 2025, from <a href="https://cps.ca/mental-health-screening-tools" rel="ugc noopener noreferrer" target="_blank">https://cps.ca/mental-health-screening-tools</a></li></ul><p>For more PsychEd, follow us on Instagram (<a href="https://www.instagram.com/psyched.podcast/" rel="ugc noopener noreferrer" target="_blank">@psyched.podcast</a>), X (<a href="https://twitter.com/psychedpodcast" rel="ugc noopener noreferrer" target="_blank">@psychedpodcast</a>), and Facebook (<a href="https://www.facebook.com/PsychEdPodcast" rel="ugc noopener noreferrer" target="_blank">PsychEd Podcast</a>). You can provide feedback by email at <a href="mailto:[email protected]" rel="ugc noopener noreferrer" target="_blank">[email protected]</a>. For more information, visit our website at <a href="http://psychedpodcast.org/" rel="ugc noopener noreferrer" target="_blank">psychedpodcast.org</a>.</p>